Both receptor tyrosine kinase RET and dual-specificity kinase DUSP4 are implicated in ALK oncogenic action via ERK-ETV5-RET signaling, and their high expression is associated with a poor prognosis in NBs (51, 52). This evidence concerns the gene ETV5 and Nijmegen breakage syndrome.